Aptinyx Balance Sheet Health
Financial Health criteria checks 3/6
Aptinyx has a total shareholder equity of $18.3M and total debt of $25.1M, which brings its debt-to-equity ratio to 137.5%. Its total assets and total liabilities are $48.0M and $29.7M respectively.
Key information
137.5%
Debt to equity ratio
US$25.10m
Debt
| Interest coverage ratio | n/a |
| Cash | US$44.57m |
| Equity | US$18.26m |
| Total liabilities | US$29.71m |
| Total assets | US$47.96m |
Recent financial health updates
Recent updates
Aptinyx musculoskeletal pain drug NYX-2925 fails mid-stage study
Aug 12We're Keeping An Eye On Aptinyx's (NASDAQ:APTX) Cash Burn Rate
Aug 18
Aptinyx: CNS Drug Discoverer With Depressed Price
Jul 21Aptinyx updates on mid-stage clinical program for PTSD therapy
Jun 15Aptinyx (NASDAQ:APTX) Is In A Good Position To Deliver On Growth Plans
Apr 13Did You Miss Aptinyx's (NASDAQ:APTX) 15% Share Price Gain?
Mar 09What Kind Of Shareholders Hold The Majority In Aptinyx Inc.'s (NASDAQ:APTX) Shares?
Jan 30
Aptinyx recommences Phase 2 study of NYX-2925
Jan 04Have Insiders Been Buying Aptinyx Inc. (NASDAQ:APTX) Shares This Year?
Dec 26What Type Of Returns Would Aptinyx's(NASDAQ:APTX) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 27Financial Position Analysis
Short Term Liabilities: APTX's short term assets ($47.8M) exceed its short term liabilities ($9.3M).
Long Term Liabilities: APTX's short term assets ($47.8M) exceed its long term liabilities ($20.4M).
Debt to Equity History and Analysis
Debt Level: APTX has more cash than its total debt.
Reducing Debt: APTX's debt to equity ratio has increased from 0% to 137.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if APTX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if APTX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/01/03 23:35 |
| End of Day Share Price | 2023/12/29 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aptinyx Inc. is covered by 11 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gary Nachman | BMO Capital Markets Equity Research |
| Charles Duncan | Cantor Fitzgerald & Co. |
| Raghuram Selvaraju | H.C. Wainwright & Co. |